Skip to main content
LIFECORE BIOMEDICAL, INC. \DE\ logo

LIFECORE BIOMEDICAL, INC. \DE\ — Investor Relations & Filings

Ticker · LFCR ISIN · US5147661046 LEI · 549300EHBZ5OM9ND9O43 US Manufacturing
Filings indexed 1,096 across all filing types
Latest filing 2016-02-08 Director's Dealing
Country US United States of America
Listing US LFCR

About LIFECORE BIOMEDICAL, INC. \DE\

https://www.lifecore.com/

Lifecore Biomedical is an integrated contract development and manufacturing organization (CDMO) that specializes in sterile injectable pharmaceutical drug products and medical devices. The company provides a full range of services, including specialty formulation, process development, aseptic filling, and final packaging, supporting products from clinical phases through to commercial supply. A key area of expertise is the handling of complex and highly viscous formulations. In addition to its CDMO capabilities, Lifecore is a primary producer of non-animal-sourced sodium hyaluronate (hyaluronic acid), offering it in various molecular weights and formats, including bulk material, hydrogels, and filled syringes and vials for diverse applications.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2016-02-08 English
FORM 4
Director's Dealing
2016-02-03 English
Major Shareholding Notification 2016
Major Shareholding Notification
2016-01-26 English
FORM 10-Q
Interim / Quarterly Report Q2 2016
2016-01-07 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated January 6, 2016, reporting the issuance of a press release announcing consolidated financial results for the second quarter of fiscal year 2016. The text explicitly states that the press release is furnished as Exhibit 99.1 and that the information is being furnished, not filed, and is not incorporated by reference in other filings. The document itself does not contain detailed financial statements or substantive financial data but rather announces the release of financial results via a press release. This matches the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only. The document length is 3128 characters, which is relatively short and consistent with an earnings release announcement rather than a full interim report or annual report. Therefore, the appropriate classification is Earnings Release (ER).
2016-01-06 English
FORM 4
Director's Dealing
2015-11-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.